within Pharmacolibrary.Drugs.D_Dermatologicals.D02B_ProtectivesAgainstUvRadiation.D02BB02_Afamelanotide;
model Afamelanotide 
   extends Pharmacolibrary.Drugs.ATC.D.D02BB02;

  annotation(Documentation(
    info ="<html><body><p>Afamelanotide is a synthetic analogue of alpha-melanocyte stimulating hormone (α-MSH) used for the treatment of erythropoietic protoporphyria (EPP) to reduce photosensitivity and phototoxic reactions. It is administered as a subcutaneous implant and is approved for use in the European Union, Australia, and the United States.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters in healthy adults based on available public summaries and regulatory documents. No full peer-reviewed population PK modeling study available.</p><h4>References</h4><ol><li><p>Minder, EI, et al., &amp; Schneider-Yin, X (2017). Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders. <i>Clinical pharmacokinetics</i> 56(8) 815–823. DOI:<a href=&quot;https://doi.org/10.1007/s40262-016-0501-5&quot;>10.1007/s40262-016-0501-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28063031/&quot;>https://pubmed.ncbi.nlm.nih.gov/28063031</a></p></li><li><p>Kim, ES, &amp; Garnock-Jones, KP (2016). Afamelanotide: A Review in Erythropoietic Protoporphyria. <i>American journal of clinical dermatology</i> 17(2) 179–185. DOI:<a href=&quot;https://doi.org/10.1007/s40257-016-0184-6&quot;>10.1007/s40257-016-0184-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26979527/&quot;>https://pubmed.ncbi.nlm.nih.gov/26979527</a></p></li><li><p>Sato, A, et al., &amp; Yamamoto, Y (2024). Discovery of MT-7117 (Dersimelagon Phosphoric Acid): A Novel, Potent, Selective, and Nonpeptidic Orally Available Melanocortin 1 Receptor Agonist. <i>Journal of medicinal chemistry</i> 67(24) 21729–21748. DOI:<a href=&quot;https://doi.org/10.1021/acs.jmedchem.4c02358&quot;>10.1021/acs.jmedchem.4c02358</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39641249/&quot;>https://pubmed.ncbi.nlm.nih.gov/39641249</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Afamelanotide;
